ArticleJugan geon-gang gwa jilbyeong2023
[The Republic of Korea National Influenza Vaccination Project: Outcomes of the 2022-2023 Season].
Article in Jugan geon-gang gwa jilbyeong, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Behavioral and psychosocial factors associated with coadministration of COVID-19 and influenza vaccines among the elderly.BMC public health · 2026Article
- Socioeconomic disparities in influenza vaccination uptake: impact of the COVID-19 pandemic in South Korea.BMC public health · 2025Article
- Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly.Human vaccines & immunotherapeutics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The national influenza vaccinations program has implemented for the adults aged 65 years and older, pregnant women and children aged 6 months to 13 years. This article introduces the main results of the national influenza vaccination program for the 2022-2023 season. The vaccination rate of each target group was 81.9% for the older adults, an increase of 1.4%p from the previous year, and 50.4% and 71.0% for pregnant women and children, respectively (a decrease of 3.8%p and 2.8%p, respectively, from the previous year). A total of 118 reports of adverse reactions after influenza vaccination were reported, similar to the previous year. Based on the main results from the 2022-2023 season, it is expected to be used as baseline data for the development of national influenza vaccination in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.